Micronics to Develop HBV, HCV, HIV Tests for NAT System Under $2.6M DoD Grant
October 21, 2010
Micronics to Develop HBV, HCV, HIV Tests for NAT System Under $2.6M DoD Grant
The Applied Research and Technology Development Award is the single largest amount of non-dilutive funding received by Micronics to date and will help the company add to the menu of tests under development for PanNAT, the company's portable system for nucleic acid amplification-based point-of-care testing.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Micronics Gets $2.6M Grant for MDx Blood Screening
October 18, 2010 / GenomeWeb Daily News - PerkinElmer Buys Shanghai Haoyuan for Near-Term Blood Screening Play, Longer Term MDx Initiative
November 15, 2012 / PCR Insider - Data Show Novartis/Gen-Probe Test Curbs HIV, HBV Transmission in South African Blood Supply
July 28, 2011 / PCR Insider - NEJM Study of Gen-Probe Assay Backs Use of Triplex NAT in HBV Blood Screening
January 20, 2011 / PCR Insider - Alere Provides Update on Commercialization Timeline for Nucleic Acid-Based Testing Platforms
February 28, 2013 / PCR Insider